miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway

Jing Han(Hainan General Hospital), Zhengtang Chen(Army Medical University)
International Journal of Oncology
February 19, 2016
Cited by 68


Related Papers